TCR Alpha/Beta Depletion for HSCT From Haploidentical and Unrelated Donors in the Treatment of PID

Clinical trial NCT02327351 · COMPLETED

Trial details

NCT number: NCT02327351
Sponsor: Federal Research Institute of Pediatric Hematology, Oncology and Immunology
Status: COMPLETED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Primary Immune Deficiency Disorder Hematopoietic Stem Cell Transplantation

Start date: 2012-07-01
Primary completion: 2017-12-01
Enrollment: 98

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.